Intuitive Surgical, Inc.
At today's price, Intuitive Surgical, Inc. (ISRG) is priced for today's economics sustained for ~13.1 years. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high. Built from SEC EDGAR filings.
• Intuitive Surgical dominates robotic surgery: it places da Vinci systems in hospitals, then earns recurring revenue every time a surgeon uses them, the razor-and-blade model applied to the operating room. • The decisive number is procedure growth: worldwide da Vinci and Ion procedures grew about 17% in the most recent quarter, with the new da Vinci 5 driving an upgrade cycle [Source: Intuitive Surgical Q1 2026 earnings release]. • The defining risk is the price: only the forward-growth method
Is ISRG overvalued? See what's priced in →
2,252 institutional managers reported holding ISRG in 13F filings for the quarter ended 2026-03-31. Together they hold about 80% of the company; the top 10 hold 36%. 133 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 7.8M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (3.1 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ISRG's share count is about flat over the past five years ($6.44B of repurchases, offset by issuance). It stopped paying its dividend within the past year. Cash returned over the past three years: $3.48B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at ISRG over the trailing three years. Absence is a fact about the company, not a signal. 23 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ISRG's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-25 | -3.7% | -12.1% |
| 2023-10-21 | -3.1% | +26.0% |
| 2024-02-01 | -1.5% | -1.3% |
| 2024-04-20 | -2.1% | +18.1% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ISRG's latest 8-K filings: 2026-05-28 (items 5.02, 9.01); 2026-05-04 (items 5.02, 5.07, 7.01); 2026-04-21 (items 2.02, 9.01); 2026-03-02 (items 8.01, 9.01); 2026-01-22 (items 2.02, 9.01).
Item codes are the SEC's own classification of what each report discloses. Nothing here is investment advice.
Last analyzed: June 27, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.